Follow

"Over the past few days, presentations at the American Diabetes Association meeting in San Diego have delivered a slew of findings that suggest the Age of Ozempic is already over. Taking its place: a parade of better treatments for obesity. "

theatlantic.com/health/archive

Sign in to participate in the conversation
CleverLibre Social

CleverLibre Social is an inclusive social instance for open discussion, learning, and community.
All cultures welcome.
Hate speech and harassment strictly forbidden.